S2Medical AB Class B (S21) Stock Statistics & Valuation Metrics

S2Medical AB Class B has a market cap or net worth of €951.04K. The enterprise value is ―.

S2Medical AB Class B has 836,139,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

S2Medical AB Class B’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of S2Medical AB Class B is 1.02. S2Medical AB Class B’s PEG ratio is >-0.01.

In the last 12 months, S2Medical AB Class B had revenue of 14.91M and earned 5.77M in profits. Earnings per share was 0.01.

In the last 12 months, operating cash flow was 14.45M and capital expenditures -1.14M, giving a free cash flow of 13.31M billion.

S2Medical AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―

S2Medical AB Class B upcoming earnings date is Aug 22, 2025, TBA Not Confirmed.

S2Medical AB Class B as a current ratio of 0.90, with Debt / Equity ratio of 0.00%

In the past 12 months, S2Medical AB Class B has paid 0.00 in taxes.

S2Medical AB Class B EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

S2Medical AB Class B has €1.37M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€1.37M billion.

Gross margin is -26.35%, with operating margin of 38.85%, and net profit margin of 38.72%.

The average price target for S2Medical AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―